When 10,000 doctors stood up and cheered for a cancer drug — America’s innovation machine made it possible

You might have seen, in early June, more than 10,000 oncologists and drug developers gave a standing ovation mid-presentation. The slide that moved the room showed survival curves for Revolution Medicine’s daraxonrasib. For the first time, a drug showed a path to beating pancreatic cancer, nearly doubling survival. Thanks to social media, millions more shared that moment.Recommended Video Over the last half-dozen years of my 25-year career in biotech, I’ve enjoyed more and more moments like this. The vast majority have been thanks to U.S. leadership in drug innovation. But we are at an important crossroads. American patients face high healthcare costs at home, while the rise of China and AI adds new anxieties.

…

Excerpt limited to ~120 words for fair-use compliance. The full article is at Fortune.